2012
DOI: 10.1155/2012/132085
|View full text |Cite
|
Sign up to set email alerts
|

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies

Abstract: We are presenting a case of renal failure with anti-GBM and p-ANCA antibodies positive. Patients with dual antibodies are considered to be a vasculitis-variant of anti-GBM antibody nephritis. These patients may have atypical presentation and it may delay diagnosis and treatment. Recurrence rate is higher in these patients. We reviewed the literature of cases and studies on cresenteric glomerulonephritis with anti-GBM and p-ANCA positive patients. We recommend that patients suspected with pulmonary-renal syndro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Up to 20-25% of patients with anti-GBM antibody nephritis have associated ANCA positivity (3). On the other hand, 5% of ANCA-associated GN patients have anti-GBM antibodies in their sera (4). Interestingly, our patient had both types of ANCA antibodies, a phenomenon very rarely reported in literature.…”
Section: What Is the Significance Of Dual Positivity Of Anti-gbm And mentioning
confidence: 39%
“…Up to 20-25% of patients with anti-GBM antibody nephritis have associated ANCA positivity (3). On the other hand, 5% of ANCA-associated GN patients have anti-GBM antibodies in their sera (4). Interestingly, our patient had both types of ANCA antibodies, a phenomenon very rarely reported in literature.…”
Section: What Is the Significance Of Dual Positivity Of Anti-gbm And mentioning
confidence: 39%
“…McAdoo et al in Although co-presentation with both ANCA (MPO or PR3) and anti-GBM antibodies is a well-recognized entity [3], the underlying mechanism of this association remains unclear [2,3,5,6]. Several hypotheses have been proposed and the most attractive seems to be the existence of an ANCA-induced glomerular inflammation as a trigger to produce GBM autoantibodies [1,2,[6][7][8][9]. In this patient, the longer duration of constitutional symptoms and the presence of both active and chronic lesions in renal biopsy also suggest that ANCA-mediated glomerular inflammation may have precede the onset of anti-GBM disease.…”
Section: Discussionmentioning
confidence: 99%
“…About 10-40% [5,6] of anti-GBM antibody-positive patients also had positive ANCA, usually myeloperoxidase (MPO)-ANCA [1,2,6,7], and 5-14% [6] of ANCA-positive patients had positive anti-GBM antibodies [1]. The clinical presentation may be atypical [2], resulting in delay of the correct diagnosis and appropriate treatment [2,8] with significant morbidity and mortality [2].…”
Section: Introductionmentioning
confidence: 99%
“…It is hypothesized that ANCA may play an important role in the development of anti-GBM disease by causing damage to the GBM and exposing the target antigen, thereby triggering production of anti-GBM antibodies ( 7 ). The correct diagnosis and initiation of treatment may be delayed in some patients with DPD due to an atypical presentation of pulmonary-renal syndrome (PRS) ( 8 ).…”
Section: Introductionmentioning
confidence: 99%